Medpace Form 144: 7,500-share insider sale planned for July 2025

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) filed a Form 144 indicating an intended sale of 7,500 common shares through Fidelity Brokerage Services. The shares have an aggregate market value of $3.38 million, implying a per-share reference price of roughly $450 based on the data provided.
• Approximate sale date: 07/28/2025 on Nasdaq
• Shares outstanding: 28,093,026, so the proposed sale represents about 0.03 % of shares outstanding.
• Shares were acquired on 10/24/2023 via stock-option exercise paid in cash.
• No other sales have been reported by this filer in the past three months.

The signer certified no undisclosed material adverse information and affirmed compliance with Rule 10b5-1, if applicable. No further financial results or company-level disclosures accompany this notice.

Positive

• None.

Negative

• Insider intends to sell 7,500 shares worth $3.38 M, which can signal profit-taking and create modest negative sentiment, although the stake is immaterial.

Insights

Securities Analyst

TL;DR: Minor insider Form 144—7,500 MEDP shares (~$3.4 M, 0.03 % float); limited market impact, slightly negative sentiment.

The filing merely signals a potential disposition, not a completed trade. Volume is small relative to MEDP’s market capitalization and daily trading volume, so liquidity risk is negligible. However, any insider sale can be perceived negatively because it suggests profit-taking. The options-exercise origin and lack of prior 3-month sales temper bearish interpretation. Overall, the disclosure is routine and unlikely to alter the investment thesis barring larger follow-on sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7500	3376083.14	28093026	07/28/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/24/2023	Stock Option Exercise	Issuer			7500	10/24/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Medpace (MEDP) shares are being registered for sale in this Form 144?

The notice covers 7,500 common shares.

What is the estimated market value of the proposed MEDP share sale?

The aggregate market value is listed as $3,376,083.14.

When is the planned sale date for the MEDP shares?

The filer lists an approximate sale date of 07/28/2025.

What percentage of Medpace’s outstanding shares does the sale represent?

With 28,093,026 shares outstanding, the 7,500-share sale equals roughly 0.03 % of total shares.

How were the shares acquired by the insider?

They were obtained through a stock-option exercise on 10/24/2023, paid in cash.